Clinical Investigation of Mycoplasma Pneumoniae Infection in Pediatrics
碩士 === 國立中山大學 === 醫務管理研究所 === 101 === Background Mycoplasma pneumoniae (M. pneumoniae) is a major cause of pediatric community‐acquired pneumonia (CAP), accounting for approximately 15% of all CAP cases. Treatment with macrolide antibiotics is recommended. However, diagnosis of M. pneumoniae infecti...
Main Authors: | Tzu-Yu Ho, 何慈育 |
---|---|
Other Authors: | Ying-Chun Li |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/48432943487401567867 |
Similar Items
-
Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia
by: Yu-Chin Chen, et al.
Published: (2020-07-01) -
High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia
by: Jinrong Liu, et al.
Published: (2019-12-01) -
Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients
by: Jin-Rong Liu, et al.
Published: (2018-10-01) -
The epidemiology and clinical features of Mycoplasma pneumoniae infection in neonates
by: Feng Huang, et al.
Published: (2016-07-01) -
Immunological Features of Pediatric Interstitial Pneumonia Due to Mycoplasma pneumoniae
by: Xuefeng Xu, et al.
Published: (2021-04-01)